Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
AVDL
#1632
Avadel Pharmaceuticals plc
21.640
0
+0.05%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+0.05%
Monatliche Änderung
+0.70%
6 month change
+16.66%
Jahresänderung
+16.66%
Vorheriger Schlusskurs
21.630
0
Open
21.640
0
Bid
Ask
Low
21.640
0
High
21.640
0
Volumen
1 054
Märkte
Aktien
Gesundheitswesen
AVDL
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
96.36 M
96.63 M
96.74 M
97.1 M
97.66 M
—
Valuation ratios
Enterprise value
1.24 B
964.2 M
701.1 M
795.91 M
1.41 B
3.87 B
Price to earnings ratio
-17.49
-20.61
-30.12
-442.5
1 527
1 033.78
Price to sales ratio
8.8
5.91
3.87
3.88
6.05
19.71
Price to cash flow ratio
14.04
21.32
29.75
245.86
83.12
380.06
Price to book ratio
3.8
13.54
2.57
2.74
4.45
23.3
Enterprise value to EBITDA ratio
-19.3
-22.81
—
—
—
—
Profitability ratios
Return on assets %
-0.02
-0.03
-0.03
-0
-0.05
-0.11
Return on equity %
-0.04
-0.07
-0.07
-0
-0.1
-0.24
Return on invested capital %
3.1
-27.86
-25.15
11.86
-11.6
-52.75
Gross margin %
87.7
90.45
89.38
90.66
105.31
375.8
Operating margin %
0.65
-6.54
-5.71
4.23
-5.25
-13.27
EBITDA margin %
-0.65
-6.54
—
—
—
—
Net margin %
-5.25
-10
-9.37
-0.26
-12.68
-32.31
Liquidity ratios
Quick ratio
2.6
2.33
2.33
2.38
2.37
9.42
Current ratio
2.97
2.75
2.73
2.79
2.76
11.03
Inventory turnover
0.42
0.26
0.27
0.29
-0.17
0.65
Asset turnover
0.32
0.31
0.32
0.38
0.4
1.41
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.07
0.08
-0.09
0.13
0.22
0.35
EBIT per share
-0
-0.03
-0.03
0.09
0.02
0.04
EBITDA per share
-0
-0.03
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.69
0.78
0.69
0.82
0.92
3.21
Net current asset value per share
1.34
1.41
1.44
1.61
1.73
6.19
Tangible book value per share
0.61
0.6
0.59
0.75
0.82
2.75
Working capital per share
0.89
0.9
0.91
1.03
1.1
3.94
Book value per share
0.79
0.78
0.77
0.92
0.98
3.44
Nachrichten
Alkermes vor Quartalszahlen: Neue Schlafstrategie im Fokus der Anleger
Alkermes earnings up next as sleep strategy takes shape
Harmony Biosciences Makes The Grade (NASDAQ:HRMY)
Alkermes stock price target raised to $47 from $46 at UBS on Avadel deal
BlackRock legt 6,94-prozentige Beteiligung an Avadel Pharmaceuticals offen
BlackRock discloses 6.94% stake in Avadel Pharmaceuticals
TIG Advisors meldet 4,18 %-Beteiligung an Avadel Pharmaceuticals
TIG Advisors discloses 4.18% stake in Avadel Pharmaceuticals
Goldman Sachs legt Handelsposition in Avadel Pharmaceuticals offen
Goldman Sachs discloses trading position in Avadel Pharmaceuticals
Janus Henderson meldet Beteiligung von 1,87 % an Avadel Pharmaceuticals
Janus Henderson discloses 1.87% stake in Avadel Pharmaceuticals